Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.210
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Peering Into Ocugen's Recent Short Interest
August 09, 2024
Via
Benzinga
Ocugen (OCGN) Q2 2024 Earnings Call Transcript
August 08, 2024
OCGN earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Ocugen Provides Business Update with Second Quarter 2024 Financial Results
August 08, 2024
From
Ocugen
Via
GlobeNewswire
InvestorNewsBreaks – Ocugen Inc. (NASDAQ: OCGN) Closes on $35M Public Offering
August 06, 2024
Via
Investor Brand Network
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa
August 05, 2024
From
Ocugen
Via
GlobeNewswire
Why Ocugen (OCGN) Stock Is Falling
August 01, 2024
Ocugen shares are trading lower by 11% Thursday morning. The company announced the pricing of its public offering.
Via
Benzinga
Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock
August 02, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
July 31, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
July 31, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results
July 29, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Novel Modifier Gene Therapy
July 25, 2024
From
Ocugen
Via
GlobeNewswire
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
July 11, 2024
These two stocks could have vastly different long-term performances.
Via
The Motley Fool
3 Penny Stocks That Could Turn $10K Into $100K in 3 Years
July 06, 2024
Discover three high-potential penny stocks that could derive 10X returns in biotechnology, silver and oil and gas storage and transportation.
Via
InvestorPlace
7 A-Rated Penny Stocks to Beat June Gloom
June 24, 2024
Some penny stocks can be diamonds in the rough. These A-rated penny stocks are all solid picks for a portfolio this month.
Via
InvestorPlace
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease
June 21, 2024
From
Ocugen
Via
GlobeNewswire
3 Penny Stocks Set to Make New Millionaires in 2024
June 20, 2024
Explore the best penny stocks to buy and their progressive fundamentals in biotechnology, healthcare, and electrical components.
Via
InvestorPlace
Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication
June 20, 2024
From
Ocugen
Via
GlobeNewswire
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 20, 2024
Via
Benzinga
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation.
Via
InvestorPlace
OCGN DEADLINE TODAY: TOP RANKED ROSEN LAW FIRM Encourages Ocugen, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm – OCGN
June 10, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
OCGN DEADLINE TODAY: ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm – OCGN
June 10, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm
June 10, 2024
From
The Schall Law Firm
Via
Business Wire
OCGN DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
June 09, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
OCGN DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
June 09, 2024
WHY: NEW YORK, NY - (NewMediaWire) - June 09, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc. (NASDAQ: OCGN) between May 8, 2020 and April 1,...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
June 08, 2024
WHY: NEW YORK, NY - (NewMediaWire) - June 08, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc. (NASDAQ: OCGN) between May 8, 2020 and April 1,...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
June 08, 2024
WHY: NEW YORK, NY - (NewMediaWire) - June 08, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc. (NASDAQ: OCGN) between May 8, 2020 and April 1,...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm
June 07, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
OCUGEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ocugen, Inc. and Encourages Investors to Contact the Firm
June 07, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
TOP RANKED ROSEN LAW FIRM Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
June 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
TOP RANKED ROSEN LAW FIRM Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
June 07, 2024
WHY: NEW YORK, NY - (NewMediaWire) - June 07, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc. (NASDAQ: OCGN) between May 8, 2020 and April 1,...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.